|
⚲
|
| Keyboard |
| Nohria Virinder
✚
|
|
|---|---|
| CIK # | 0001619077 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001619077] | |
| 4 | [0001619077] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Nohria Virinder | |
| Progenics Pharmaceuticals Inc | |
| Horizon Therapeutics Public Ltd Co |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Horizon Therapeutics Public Ltd Co HZNP
Restricted Stock Units · derivative
|
2017-05-03 | Grant | 14,054 | $0.00 | |
|
Horizon Therapeutics Public Ltd Co HZNP
Restricted Stock Units · derivative
|
2017-05-03 | Option exercise | 13,953 | $0.00 | |
|
Horizon Therapeutics Public Ltd Co HZNP
Stock Option (Right to Buy) · derivative
|
2017-05-03 | Grant | 31,153 | $0.00 | |
|
Horizon Therapeutics Public Ltd Co HZNP
Ordinary Shares
|
2017-05-03 | Option exercise | 13,953 | ||
|
Horizon Therapeutics Public Ltd Co HZNP
Ordinary Shares
|
2016-06-15 | Sell | 25,000 | $17.69 | 442,250 |
|
Horizon Therapeutics Public Ltd Co HZNP
Ordinary Shares
|
2016-05-06 | Option exercise | 5,258 | ||
|
Horizon Therapeutics Public Ltd Co HZNP
Restricted Stock Units · derivative
|
2016-05-06 | Option exercise | 5,258 | $0.00 | |
|
Horizon Therapeutics Public Ltd Co HZNP
Restricted Stock Units · derivative
|
2016-05-03 | Grant | 13,953 | $0.00 | |
|
Horizon Therapeutics Public Ltd Co HZNP
Stock Option (Right to Buy) · derivative
|
2016-05-03 | Grant | 23,092 | $0.00 | |
|
Horizon Therapeutics Public Ltd Co HZNP
Restricted Stock Units · derivative
|
2015-05-06 | Grant | 5,258 | $0.00 | |
|
Horizon Therapeutics Public Ltd Co HZNP
Stock Option (Right to Buy) · derivative
|
2015-05-06 | Grant | 8,548 | $0.00 | |
|
Horizon Therapeutics Public Ltd Co HZNP
Ordinary shares, nominal value $0.0001 per share
|
2014-11-13 | Sell | 1,739,130 | $11.54 | 20,069,560 |
|
Horizon Therapeutics Public Ltd Co HZNP
Ordinary shares, nominal value $0.0001 per share
|
2014-09-22 | Other | 2,214,836 |